Dynavax (DVAX) Announces Date for FDA Panel Review of HEPLISAV-B
Go back to Dynavax (DVAX) Announces Date for FDA Panel Review of HEPLISAV-B| Dynavax Technologies Corporation (NASDAQ: DVAX) | Delayed: 11.21 +0.04 (0.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.17 | 52 Week High | $29.86 | |||
| Open | $11.11 | 52 Week Low | $3.20 | |||
| Day High | $11.26 | P/E | N/A | |||
| Day Low | $11.03 | EPS | $-0.41 | |||
| Volume | 1,876,092 | |||||
